EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection

Qu Xie, Zeyin Zhao, Yanzhen Yang, Xiaohong Wang, Wei Wu, Haitao Jiang, Weiyuan Hao, Ruizi Peng, Cong Luo iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Qu Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local, Tomography, X-Ray Computed. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Basic Public Welfare Research Program, Zhejiang Provincial Traditional Chinese Medicine Science and Technology Program, Zhejiang Traditional Chinese Medicine Scientific Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Radical surgery, the first‐line treatment for patients with hepatocellular cancer (HCC), faces the dilemma of high early recurrence rates and the inability to predict effectively. We aim to develop and validate a multimodal model combining clinical, radiomics, and pathomics features to predict the risk of early recurrence. Materials and Methods We recruited HCC patients who underwent radical surgery and collected their preoperative clinical information, enhanced computed tomography (CT) images, and whole slide images (WSI) of hematoxylin and eosin (H & E) stained biopsy sections. After feature screening analysis, independent clinical, radiomics, and pathomics features closely associated with early recurrence were identified. Next, we built 16 models using four combination data composed of three type features, four machine learning algorithms, and 5‐fold cross‐validation to assess the performance and predictive power of the comparative models.

Results

Between January 2016 and December 2020, we recruited 107 HCC patients, of whom 45.8% (49/107) experienced early recurrence. After analysis, we identified two clinical features, two radiomics features, and three pathomics features associated with early recurrence. Multimodal machine learning models showed better predictive performance than bimodal models. Moreover, the SVM algorithm showed the best prediction results among the multimodal models. The average area under the curve (AUC), accuracy (ACC), sensitivity, and specificity were 0.863, 0.784, 0.731, and 0.826, respectively. Finally, we constructed a comprehensive nomogram using clinical features, a radiomics score and a pathomics score to provide a reference for predicting the risk of early recurrence.

Conclusions

The multimodal models can be used as a primary tool for oncologists to predict the risk of early recurrence after radical HCC surgery, which will help optimize and personalize treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNeoplasm Recurrence, LocalTomography, X-Ray ComputedMachine LearningHumansMaleFemaleMiddle AgedPrognosisAgedHepatectomyAdultRadiomics

Stichwörter der Autor:innen

hepatocellular carcinomamachine learningpathomicsradiomicsrecurrence

Autor:innen und Institutionen

  • Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Provi…
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Department of Intestinal Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
  • Department of Pathology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.

ORCID-Profile: Cong Luo

Förderung

  • Zhejiang Basic Public Welfare Research Program
  • Zhejiang Provincial Traditional Chinese Medicine Science and Technology Program
  • Zhejiang Traditional Chinese Medicine Scientific Research Fund

Zitieren

APA

Xie, Q., Zhao, Z., Yang, Y., Wang, X., Wu, W., Jiang, H., Hao, W., Peng, R., & Luo, C. (2024). A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection. Cancer Medicine. https://doi.org/10.1002/cam4.7374

Vancouver

Xie Q, Zhao Z, Yang Y, Wang X, Wu W, Jiang H, et al. A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection. Cancer Medicine. 2024. doi:10.1002/cam4.7374

BibTeX
@article{Xie2024,
  author = {Xie, Qu and Zhao, Zeyin and Yang, Yanzhen and Wang, Xiaohong and Wu, Wei and Jiang, Haitao and Hao, Weiyuan and Peng, Ruizi and Luo, Cong},
  title = {A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7374}
}
Kostenlos starten →